Healthpeak Properties (NYSE:DOC) Price Target Raised to $22.00

Healthpeak Properties (NYSE:DOC) had its price target raised by Wells Fargo & Company from $20.00 to $22.00 in a research note issued to investors on Wednesday, Marketbeat.com reports. The firm currently has an equal weight rating on the real estate investment trust’s stock.

DOC has been the subject of a number of other reports. BMO Capital Markets increased their price target on shares of Healthpeak Properties from $20.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, June 15th. Robert W. Baird lifted their price objective on Healthpeak Properties from $19.00 to $21.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. Evercore downgraded Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 target price on the stock. in a report on Monday, May 11th. Morgan Stanley reissued an “equal weight” rating and issued a $22.00 target price (up from $20.00) on shares of Healthpeak Properties in a research report on Thursday, June 11th. Finally, Scotiabank increased their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock a “sector perform” rating in a research report on Wednesday, May 27th. Four research analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the stock. Based on data from MarketBeat, Healthpeak Properties presently has a consensus rating of “Hold” and a consensus price target of $20.62.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $22.52 on Wednesday. The stock has a market cap of $15.53 billion, a P/E ratio of 70.39, a price-to-earnings-growth ratio of 3.47 and a beta of 1.02. The firm’s fifty day simple moving average is $20.47 and its 200 day simple moving average is $18.24. Healthpeak Properties has a twelve month low of $15.70 and a twelve month high of $22.62. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping the consensus estimate of $0.43 by $0.02. The business had revenue of $752.95 million during the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, research analysts predict that Healthpeak Properties will post 1.75 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a dividend yield of 5.4%. Healthpeak Properties’s dividend payout ratio (DPR) is presently 381.25%.

Insider Activity

In related news, insider Scott R. Bohn sold 10,989 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider owned 7,636 shares in the company, valued at $148,520.20. The trade was a 59.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.23% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of DOC. WPG Advisers LLC grew its holdings in shares of Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust’s stock valued at $26,000 after buying an additional 1,197 shares during the last quarter. Advocate Investing Services LLC purchased a new position in Healthpeak Properties in the 4th quarter worth approximately $26,000. Elyxium Wealth LLC purchased a new position in Healthpeak Properties in the 4th quarter worth approximately $31,000. Clearstead Advisors LLC lifted its position in Healthpeak Properties by 166.3% in the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock valued at $31,000 after acquiring an additional 1,216 shares in the last quarter. Finally, CYBER HORNET ETFs LLC bought a new position in Healthpeak Properties in the 2nd quarter valued at approximately $33,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.